Costly hepatitis drug Sovaldi rattles industry

By

Article Reprint

When the Food and Drug Administration approved a medication called Sovaldi in December, it was hailed as a breakthrough in the fight against hepatitis C, a blood-borne disease that affects 3.2 million Americans and kills more people in the U.S. annually than AIDS.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: